PSTI logo

Pluristem Therapeutics (PSTI) Revenue

Annual Revenue

$234.00 K
0.00%

01 June 2022

PSTI Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Revenue

$87.00 K
0.00%

01 September 2022

PSTI Quarterly Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Revenue

$321.00 K
0.00%

01 September 2022

PSTI TTM Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PSTI Revenue Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years+333.3%--

PSTI Revenue High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time-91.8%-96.8%-89.4%

Pluristem Therapeutics Revenue History

DateAnnualQuarterlyTTM
Sept 2022
-
$87.00 K(-62.8%)
$321.00 K(+37.2%)
June 2022
$234.00 K(+917.4%)
-
-
Mar 2022
-
$234.00 K(+917.4%)
$234.00 K(+917.4%)
June 2020
$23.00 K(-57.4%)
-
-
Dec 2019
-
$23.00 K(-54.0%)
$23.00 K(-57.4%)
June 2019
$54.00 K(+8.0%)
-
-
Dec 2018
-
$50.00 K(+1150.0%)
$54.00 K(0.0%)
Sept 2018
-
$4000.00(-92.0%)
$54.00 K(+8.0%)
June 2018
$50.00 K(-98.2%)
-
-
Dec 2017
-
$50.00 K(-98.2%)
$50.00 K(-98.4%)
June 2016
$2.85 M(+651.2%)
-
-
Dec 2015
-
$2.75 M(+2796.8%)
$3.04 M(+701.1%)
Sept 2015
-
$95.00 K(+1.1%)
$379.00 K(0.0%)
June 2015
$379.00 K
$94.00 K(-1.1%)
$379.00 K(0.0%)
DateAnnualQuarterlyTTM
Mar 2015
-
$95.00 K(0.0%)
$379.00 K(0.0%)
Dec 2014
-
$95.00 K(0.0%)
$379.00 K(0.0%)
Sept 2014
-
$95.00 K(+1.1%)
$379.00 K(0.0%)
June 2014
$379.00 K(-44.2%)
$94.00 K(-1.1%)
$379.00 K(-0.3%)
Mar 2014
-
$95.00 K(0.0%)
$380.00 K(-20.7%)
Dec 2013
-
$95.00 K(0.0%)
$479.00 K(-17.3%)
Sept 2013
-
$95.00 K(0.0%)
$579.00 K(-14.7%)
June 2013
$679.00 K(-5.2%)
$95.00 K(-51.0%)
$679.00 K(-0.9%)
Mar 2013
-
$194.00 K(-0.5%)
$685.00 K(-5.0%)
Dec 2012
-
$195.00 K(0.0%)
$721.00 K(-4.8%)
Sept 2012
-
$195.00 K(+93.1%)
$757.00 K(+5.7%)
June 2012
$716.00 K
$101.00 K(-56.1%)
$716.00 K(+16.4%)
Mar 2012
-
$230.00 K(-0.4%)
$615.00 K(+59.7%)
Dec 2011
-
$231.00 K(+50.0%)
$385.00 K(+150.0%)
Sept 2011
-
$154.00 K
$154.00 K

FAQ

  • What is Pluristem Therapeutics annual revenue?
  • What is the all time high annual revenue for Pluristem Therapeutics?
  • What is Pluristem Therapeutics quarterly revenue?
  • What is the all time high quarterly revenue for Pluristem Therapeutics?
  • What is Pluristem Therapeutics TTM revenue?
  • What is the all time high TTM revenue for Pluristem Therapeutics?

What is Pluristem Therapeutics annual revenue?

The current annual revenue of PSTI is $234.00 K

What is the all time high annual revenue for Pluristem Therapeutics?

Pluristem Therapeutics all-time high annual revenue is $2.85 M

What is Pluristem Therapeutics quarterly revenue?

The current quarterly revenue of PSTI is $87.00 K

What is the all time high quarterly revenue for Pluristem Therapeutics?

Pluristem Therapeutics all-time high quarterly revenue is $2.75 M

What is Pluristem Therapeutics TTM revenue?

The current TTM revenue of PSTI is $321.00 K

What is the all time high TTM revenue for Pluristem Therapeutics?

Pluristem Therapeutics all-time high TTM revenue is $3.04 M